<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: Type 2 Diabetes - Update</title>
	<atom:link href="http://www.prescriber.org.uk/2007/10/02/type-2-diabetes-update/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.prescriber.org.uk/2007/10/02/type-2-diabetes-update/</link>
	<description>An NHS Prescribing Advisers' Blog</description>
	<pubDate>Sat, 30 Aug 2008 02:37:24 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.1</generator>
		<item>
		<title>By: Prescribing Advice for GPs &#187; MTRAC update glitazone advice</title>
		<link>http://www.prescriber.org.uk/2007/10/02/type-2-diabetes-update/#comment-2639</link>
		<dc:creator>Prescribing Advice for GPs &#187; MTRAC update glitazone advice</dc:creator>
		<pubDate>Fri, 11 Apr 2008 09:04:02 +0000</pubDate>
		<guid isPermaLink="false">http://www.prescriber.org.uk/2007/10/02/type-2-diabetes-update/#comment-2639</guid>
		<description>[...] Current recommendations still stand. Metformin continues to be the first choice oral hypoglycaemic with a sulphonylurea [...]</description>
		<content:encoded><![CDATA[<p>[...] Current recommendations still stand. Metformin continues to be the first choice oral hypoglycaemic with a sulphonylurea [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Prescribing Advice for GPs &#187; Vildagliptin delayed</title>
		<link>http://www.prescriber.org.uk/2007/10/02/type-2-diabetes-update/#comment-2104</link>
		<dc:creator>Prescribing Advice for GPs &#187; Vildagliptin delayed</dc:creator>
		<pubDate>Wed, 07 Nov 2007 14:57:16 +0000</pubDate>
		<guid isPermaLink="false">http://www.prescriber.org.uk/2007/10/02/type-2-diabetes-update/#comment-2104</guid>
		<description>[...] Action: The gliptins are new agents and their place in therapy is where other agents have failed or are not tolerated. Previous recommendations are unchanged.  Bookmark to: What are these? Copyright Â©2007 Prescribing Advice for GPs [...]</description>
		<content:encoded><![CDATA[<p>[...] Action: The gliptins are new agents and their place in therapy is where other agents have failed or are not tolerated. Previous recommendations are unchanged.  Bookmark to: What are these? Copyright Â©2007 Prescribing Advice for GPs [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>
